- Organizations: TheiaNova
Pipeline
TheiaNova doses first patient in FIH trial on regenerative eye drop for keratoconus
Study to evaluate TN-001, formulated to reprogram corneal cells and rebuild the cornea— preventing further corneal distortion and visual deterioration.Research